Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M)

OBJECTIVE: To examine the efficacy and safety of lixisenatide (20 μg once daily, administered before the morning or evening meal) as add-on therapy in patients with type 2 diabetes insufficiently controlled with metformin alone. RESEARCH DESIGN AND METHODS: This was a 24-week, randomized, double-bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahrén, Bo, Leguizamo Dimas, Aniceto, Miossec, Patrick, Saubadu, Stéphane, Aronson, Ronnie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747937/
https://www.ncbi.nlm.nih.gov/pubmed/23536584
http://dx.doi.org/10.2337/dc12-2006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747937/
https://www.ncbi.nlm.nih.gov/pubmed/23536584
http://dx.doi.org/10.2337/dc12-2006

Ejemplares similares